Baouche Hayet, Jais Jean-Philippe, Meriem Samy, Kareche Mimi, Moranne Olivier, Vigneau Cécile, Couchoud Cécile
Department of Biostatistics, APHP-Necker-Enfants Malades Hospital, REIN Registry, Paris, France.
Department of Biostatistics, APHP-Necker-Enfants Malades Hospital, REIN Registry, University of Paris Cité, Paris, France.
Clin Kidney J. 2022 Sep 12;16(1):138-150. doi: 10.1093/ckj/sfac204. eCollection 2023 Jan.
Pregnant women with end-stage renal disease on chronic dialysis are at a high risk of maternal and foetal complications. Over the years, the prognosis of their pregnancies has improved with advances in dialysis treatments and maternal and neonatal care. We conducted this systematic review to examine the recent data on maternal and foetal outcomes in pregnant women with end-stage renal failure on chronic dialysis over the last decade.
We made a systematic review of studies on pregnant women on chronic dialysis published between 1 January 2010 and 31 December 2020. We searched the following electronic databases: Medline via PubMed, Embase and the Cochrane Library, with search strategies for each database. We checked the titles and abstracts identified by the search equation, and two independent reviewers assessed the articles retrieved. For each study, the two reviewers separately recorded the data from each selected article on a standardized data extraction form. For each article, we recorded relevant general information on the study, patient demographic characteristics, dialysis schedule, pregnancy complications and outcomes, maternal complications, and foetal and neonatal outcomes.
The literature search yielded 1668 potentially relevant abstracts. After reviewing the titles, abstracts and full text, we identified 14 studies according to the inclusion criteria. All studies were observational, nine of them were retrospective and eight were from a single-centre experience. The total number of women included in these studies was 2364 (range 8-2008) and the total number of pregnancies was 2754 (range 8-2352). The patients' ages ranged from 15 to 45 years. Obesity was observed in 808 (34.2%) women and ranged from 1 to 778. Haemodialysis was the predominant modality with 2551 (92.6%) pregnancies, and 203 (7.4%) on peritoneal dialysis. Overall, 68 out of 402 (16.9%) spontaneous miscarriages, 21 out of 402 (5.2%) therapeutic abortions and 26 (8.3%) stillbirths among 313 (stillbirths and live births) were recorded. The mean or median gestational age at delivery ranged from 25.2 to 36 weeks. The main maternal complications were preeclampsia 11.9%, hypertension 7.7% and anaemia 3.9%. Live births represented 287 (71.4%) out of 402 pregnancies, birth weight ranged from 590 to 3500 g and preterm birth was the main, most common complication in all studies, ranging from 50% to 100%. Intrauterine growth restriction was present in 5.9% and small-for-gestational-age was reported in 18.9% of neonates. There were 22 (7.6%) neonatal deaths among 287 live births and 48 (15.3%) perinatal deaths among 313 total births (stillbirths and live births).
Presumably, considering the increase in the number of publications and the total number of pregnancies reported therein, the frequency of pregnancy in patients with end-stage chronic kidney disease treated by chronic dialysis has increased. However, the practice of treating pregnant women on dialysis differs significantly among countries. These findings highlight the need to standardize the definition of outcomes and healthcare for pregnant women on dialysis.
接受慢性透析的终末期肾病孕妇面临着较高的母婴并发症风险。多年来,随着透析治疗以及母婴护理水平的提高,她们妊娠的预后情况有所改善。我们开展了这项系统评价,以研究过去十年中接受慢性透析的终末期肾衰竭孕妇的母婴结局的最新数据。
我们对2010年1月1日至2020年12月31日期间发表的关于接受慢性透析孕妇的研究进行了系统评价。我们检索了以下电子数据库:通过PubMed的Medline、Embase和Cochrane图书馆,并针对每个数据库制定了检索策略。我们检查了由检索式确定的标题和摘要,两名独立评审员对检索到的文章进行了评估。对于每项研究,两名评审员分别在标准化的数据提取表上记录从每篇选定文章中获取的数据。对于每篇文章,我们记录了有关该研究的相关一般信息、患者人口统计学特征、透析方案、妊娠并发症及结局、母亲并发症以及胎儿和新生儿结局。
文献检索共获得1668篇潜在相关摘要。在审阅标题、摘要和全文后,我们根据纳入标准确定了14项研究。所有研究均为观察性研究,其中9项为回顾性研究,8项来自单中心经验。这些研究纳入的女性总数为2364名(范围8 - 2008名),妊娠总数为2754次(范围8 - 2352次)。患者年龄在15至45岁之间。808名(34.2%)女性存在肥胖,范围为1至778名。血液透析是主要的透析方式,有2551次(92.6%)妊娠采用血液透析,203次(7.4%)采用腹膜透析。总体而言,在313例(死产和活产)中记录到402例中有68例(16.9%)自然流产、402例中有21例(5.2%)治疗性流产以及26例(8.3%)死产。分娩时的平均或中位孕周为25.2至36周。主要的母亲并发症为子痫前期11.9%、高血压7.7%和贫血3.9%。402次妊娠中有287例(71.4%)活产,出生体重范围为590至3500克,早产是所有研究中主要且最常见的并发症,范围为50%至100%。5.9%的新生儿存在宫内生长受限,18.9%的新生儿为小于胎龄儿。287例活产中有22例(7.6%)新生儿死亡,313例总出生数(死产和活产)中有48例(15.3%)围产儿死亡。
据推测,考虑到发表文章数量以及其中报告的妊娠总数的增加,接受慢性透析治疗的终末期慢性肾病患者的妊娠频率有所增加,但各国对透析孕妇的治疗方法差异显著。这些发现凸显了规范透析孕妇结局定义和医疗保健的必要性。